Revance Logo
COMPANYPRODUCTS AND PIPELINEINVESTORSCAREERSIN THE NEWSCONTACT US
ABOUTLEADERSHIPBOARDPARTNERSHIPS
SUSTAINABILITYMEDICAL EDUCATIONAL GRANTSINVESTIGATOR SPONSORED TRIALS
Company
INVESTOR RELATIONSPRESS RELEASESEVENTS + PRESENTATIONSFINANCIALS & FILINGSCORPORATE GOVERNANCE
STOCK INFORMATIONANALYST COVERAGEINVESTOR FAQSCONTACT US
Investors
OPPORTUNITIESCULTUREBENEFITS
Careers
COMPANYPRODUCTS AND PIPELINEINVESTORSCAREERSIN THE NEWSCONTACT US
Facebook logoInstagram logoTwitter logoLinkedIn logo
1222 Demonbreun St
20th Floor
Nashville, TN 37203
+1 (510) 742-3400
LoginContact Revance
Back
September 2, 2014
Revance Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 12, 2014
Revance Therapeutics Appoints Industry Veteran Arthur P. Bertolino, M.D., Ph.D., M.B.A. as Chief Medical Officer
August 12, 2014
Revance Therapeutics Releases Second Quarter 2014 Financial Results
July 29, 2014
Revance Therapeutics to Release Second Quarter 2014 Financial Results and Host Conference Call on Tuesday, August 12, 2014
June 24, 2014
Revance Therapeutics Announces Closing of Its Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
June 18, 2014
Revance Therapeutics Announces Pricing of Its Public Offering of Common Stock
June 16, 2014
Revance Therapeutics Announces Proposed Public Offering of Common Stock
May 21, 2014
Revance Therapeutics Clinical Data to be Presented in "Emerging Technologies" Panel at the International Symposium of Facial Plastic Surgery in New York City
May 21, 2014
Revance Therapeutics, Inc. Announces Participation in Jefferies 2014 Global Healthcare Conference
May 13, 2014
Revance Therapeutics Releases First Quarter 2014 Financial Results
Displaying 281 - 290 of 309